Prevention of preeclampsia with calcium supplementation and its relation with the L-arginine:nitric oxide pathway

Brazilian Journal of Medical and Biological Research

Volumn 29, Issue 6, 1996, Pages 731-741

  Lopez Jaramillo P ^a,b  

^a Facultad de Ciencias Médicas   (Ecuador)

^b NONE   (Ecuador)

Author keywords

calcium; calcium supplementation; nitric oxide; preeclampsia; pregnancy induced hypertension

Indexed keywords

ARGININE; CALCIUM; NITRIC OXIDE;

ENDOTHELIUM; FEMALE; FETUS; HEMODYNAMICS; HOMEOSTASIS; HUMAN; HYPERTENSION; MORBIDITY; MORTALITY; PREECLAMPSIA; PREGNANCY; REVIEW; VASODILATATION;

ARGININE; CALCIUM; CYCLIC GMP; FEMALE; FOOD, FORTIFIED; HEMODYNAMIC PROCESSES; HOMEOSTASIS; HUMANS; HYPERTENSION; NITRIC OXIDE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR;

EID: 0029897338     PISSN: 0100879X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (99)

1. Sullivan JM (1986). Hypertension and Pregnancy. Year Book Medical Publishers, Chicago, 3-7.
2. World Health Organization, International Collaborative Study of Hypertensive Disorders of Pregnancy (1988). Geographic variation in the incidence of hypertension in pregnancy. American Journal of Obstetrics and Gynecology, 158: 80-83.
3. MacGuillivray I (1983). Preeclampsia: The Hypertensive Disease of Pregnancy. WB Saunders, London.
4. Page EW & Christianson R (1976). The impact of mean arterial pressure in the middle trimester upon the outcome of pregnancy. American Journal of Obstetrics and Gynecology, 125: 740-746.
5. Long PA, Long DA & Beischer NA (1980). Fetal growth retardation and preeclampsia. British Journal of Obstetrics and Gynaecology, 87: 13-18.
6. Pan American Health Organization (1986). Basic elements for the study and prevention of maternal mortality. Epidemiological Bulletin (PAHO), 7: 1-6.
7. Moscoso H & Guzmán L (1987). Situación de la salud materna y programa nacional de atención perinatal. Revista de la Facultadde Ciencias Médicas (Quito), 12: 7-12.
8. Bader ME & Bader RA (1968). Cardiovascular hemodynamics in pregnancy and labor. Clinics in Obstetrics and Gynecology, 11: 924-939.
9. Lees MM, Taylor SH, Scott DB & Kerr MG (1967). A study of cardiac output at rest throughout pregnancy. Journal of Obstetrics and Gynaecology of the British Commonwealth, 74: 319-328.
10. Metcalf J & Veland K (1974). Maternal cardiovascular adjustments to pregnancy. Progress in Cardiovascular Disease, 16: 363-374.
11. Moutquin JM, Rainville C, Giroux L, Raynauld P, Amyot G, Bilodeau R & Pelland N (1985). A prospective study of blood pressure in pregnancy: prediction of preeclampsia. American Journal of Obstetrics and Gynecology, 151: 191-206.
12. Reiss RE, O'Shaughnessy RW, Quilligan TJ & Zuspan FP (1987). Retrospective comparison of blood pressure course during preeclampsia and matched control pregnancy. American Journal of Obstetrics and Gynecology, 156: 894-898.
13. Lewis JP, Moncada S & O'Grady J (1983). Prostacyclin in Pregnancy. Raven Press, New York.
14. Abdul-Karim R & Assali NS (1961). Pressor response to angiotensin in pregnant and non-pregnant women. American Journal of Obstetrics and Gynecology, 82: 246-251.
15. Gant NF, Daley GL, Chand S, Whalley PJ & MacDonald PC (1973). A study of angiotensin II presser response throughout primigravid pregnancy. Journal of Clinical Investigation, 51: 2682-2689.
16. Everett RB, Worley RJ, MacDonald PC & Gant NF (1978). Effect of prostaglandin synthetase inhibitors on pressor response to angiotensin II in human pregnancy. Journal of Clinical Endocrinology and Metabolism, 46: 1007-1010.
17. Conrad KP & Colpoys MC (1986). Evidence against the hypothesis that prostaglandins are the vasodepressor agents of pregnancy: serial studies in chronically instrumented, conscious rats. Journal of Clinical Investigation, 77: 236-245.
18. Lopez-Jaramillo P (1993). Hipertensión Inducida por el Embarazo. Fisiopatología y Prevención. UNICEF, Ediciones Científicas, Quito.
19. Talledo OE, Chesley LC & Zuspan FP (1968). Renin-angiotensin system in normal and toxemic pregnancies. III. Differential sensitivity to angiotensin II and norepinephrine in toxemia of pregnancy. American Journal of Obstetrics and Gynecology, 100: 218-221.
20. Friedman SA (1988). Preeclampsia: A review of the role of prostaglandins. Obstetrics and Gynecology, 71: 122-137.
21. Félix C, López A, Delgado F, Amores E, Narváez M & López-Jaramillo P (1991). Vascular production of prostacyclin in Andean women with pregnancy-induced hypertension. Brazilian Journal of Medical and Biological Research, 24: 59-62.
22. Makila UM, Viinikka L & Ylikorkala O (1984). Evidence that prostacyclin deficiency is a specific feature in preeclampsia. American Journal of Obstetrics and Gynecology, 148: 772-774.
23. Remuzzi G, Marchesi D, Zoja G, Muratore D, Mecca G, Misiani R, Rossi E, Barbato M, Capelta P, Donati MB & De Gaetano G (1980). Reduced umbilical and placental vascular prostacyclin in severe preeclampsia. Prostaglandins, 20: 105-110.
24. Fitzgerald DJ, Rocki W, Murray R, Mayo G & Fitzgerald GA (1990). Thromboxane A2-synthesis in pregnancy-induced hypertension. Lancet, 335: 751-754.
25. Ylikorkala O, Pekonen F & Viinikka L (1986). Renal prostacyclin and thromboxane in normotensive and preeclamptic pregnant women and their infants. Journal of Clinical Endocrinology and Metabolism, 63: 1307-1312.
26. Schiff E, Peleg E, Goldemberg M, Rosenthal T, Ruppin E, Tamarkin M, Barkai G, Ben-Baruch G, Yahal I & Blankstein J (1989). The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. New England Journal of Medicine, 321: 351-356.
27. Widdowson EM & Dickerson JWT (1964). Chemical composition of the body. In: Comar CL & Bronner F (Editors), Mineral Metabolism. 2nd edn. Academic Press, New York.
28. Pitkin RM (1985). Calcium metabolism in pregnancy and the perinatal period: a review. American Journal of Obstetrics and Gynecology, 151: 49-109.
29. Okonofua F, Menon RK, Houlder S, Thomas M, Robinson D, O'Brien S & Dandona P (1987). Calcium, vitamin D and parathyroid hormone relationships in pregnant Caucasian and Asian women and their neonates. Annals of Clinical Biochemistry, 24: 22-28.
30. Kumar R, Cohen WR, Silva P & Epstein FH (1979). Elevated 1,25 dihydroxyvitamin D levels in normal human pregnancy. Journal of Clinical Investigation, 63: 342-344.
31. Committee on Dietary Allowances, Food and Nutrition Board (1980). Recommended daily allowances. 9th Washington Meeting of the National Academy of Science, 130.
32. Pitkin RM & Gebhardt MP (1977). Serum calcium concentration in human pregnancy. American Journal of Obstetrics and Gynecology, 127: 775-778
33. Tan CM, Raman A & Sinnathyray TA (1972). Serum ionic calcium levels during pregnancy. Journal of Obstetrics and Gynaecology of the British Commonwealth, 79: 694-697.
34. Pitkin RM, Reynolds WA, Williams GA & Hargis GKI (1979). Calcium metabolism in normal pregnancy: a longitudinal study. American Journal of Obstetrics and Gynecology, 133: 781-790.
35. López-Jaramillo P, Yépez R, Narváez M, Gaybor M, Moscoso H & Corrado AP (1988). Calcium metabolism in normal pregnancy and pregnancy induced hypertension. Jornal Brasileiro de Ginecologia, 98: 189-191.
36. Payne RP, Little AJ & Evans RT (1990). Albumin adjusted calcium concentration in serum increases during normal pregnancy. Clinical Chemistry, 36: 142-144.
37. López-Jaramillo P, Narváez M, Weigel M & Yépez R (1989). Calcium supplementation reduces the risk of pregnancy-induced hypertension in an Andean population. British Journal of Obstetrics and Gynaecology, 96: 648-655.
38. Richards SR, Nelson DM & Zuspan FP (1984). Calcium levels in normal and hypertensive pregnant patients. American Journal of Obstetrics and Gynecology, 149: 168-171.
39. Pedersen EB, Johannesen P, Kristensen S, Rasmussen AB, Emmertsen K, Moller J, Lauritsen JG & Wohlert M (1984). Calcium, parathyroid hormone and calcitonin in normal pregnancy and preeclampsia. Gynecology and Obstetrics Investigation, 18: 156-164.
40. Varner VM, Cruikshank DP & Pitkin RM (1983). Calcium metabolism in the hypertensive mother, fetus and newborn infant. American Journal of Obstetrics and Gynecology, 147: 762-765.
41. Ohara N, Yamasaki M, Morikawa H, Veda Y & Mochizuki M (1986). Dynamics of calcium metabolism and calcium-regulating hormones in pregnancy-induced hypertension. Nippon Naibumpi Gakkai Zasshi, 62: 882-896.
42. Seely EW, Wood RJ, Brown EM & Graves SW (1992). Lower serum ionized calcium and abnormal calciotropic hormone levels in preeclampsia. Journal of Clinical Endocrinology and Metabolism, 74:1436-1440.
43. Taufield PA, Ales KL & Resnik LM (1987). Hypocalciuria in preeclampsia. New England Journal of Medicine, 316: 715-718.
44. Belizán JM & Villar J (1980). The relationship between calcium intake and edema, proteinuria and hypertension gestosis: a hypothesis. American Journal of Clinical Nutrition, 33: 2201-2210.
45. Hamlin RHJ (1952). The prevention of eclampsia and preeclampsia. Lancet, i: 64-68.
46. Kesteloot H & Joossens JV (1988). Relationship of dietary sodium, potassium, calcium, and magnesium with blood pressure: Belgian interuniversity research on nutrition and health. Hypertension, 12: 594-599.
47. McCarron DA, Morris CD & Cole C (1982). Dietary calcium in human hypertension. Science, 217: 267-269.
48. Weigel M, Narváez M, Félix C, López A & López-Jaramillo P (1990). Prenatal diet, nutrient intake, and pregnancy outcome in urban Ecuadorian primiparas. Archives Latinoamericanos de Nutrición, 40: 21-37.
49. World Health Organization. (1985). Energy and protein requirements. Report of a joint FAO/WHO/UNU expert consultation Geneva, WHO Technical Report Series, no. 724.
50. López-Jaramillo P, Narváez M, Félix C & López A (1990). Dietary calcium supplementation and prevention of pregnancy hypertension. Lancet, 335: 293.
51. Narváez M, Weigel M, Félix C, López A & López-Jaramillo P (1990). The clinical utility of roll-over test in predicting pregnancy-induced hypertension in a high-risk Andean population. International Journal of Gynaecology and Obstetrics, 31: 9-14.
52. Carroli G, Duley L, Belizán JM & Villar J (1994). Calcium supplementation during pregnancy: a sistematic review of randomised controlled trials. British Journal of Obstetrics and Gynaecology, 101: 753-758.
53. Villar J, Repke J, Belizán JM & Pareja G (1987). Calcium supplementation reduces blood pressure during pregnancy: Results of a randomized controlled clinical trial. Obstetrics and Gynecology, 70: 317-322.
54. Montanaro D, Boscutti G, Mioni G, Driul P & Tosolini G (1990). Calcium supplementation decreases the incidence of pregnancy-induced hypertension (PIH) and preeclampsia (PE). Proceedings of 7th World Congress of Hypertension in Pregnancy. Perugia, Italy.
55. Villar J & Repke JT (1990). Calcium supplementation during pregnancy may reduce preterm delivery in high-risk populations. American Journal of Obstetrics and Gynecology, 163: 1124-1131.
56. Belizán JM, Villar J, Gonzáles L, Campodonico L & Bergel E (1991). Calcium supplementation to prevent hypertensive disorders of pregnancy. New England Journal of Medicine, 325: 1399-1405.
57. Cong K-J, Chi S-L & Lui G-N (1993). Calcium and pregnancy-induced hypertension. Chinese Journal of Obstetrics and Gynecology, 28: 657 (Abstract).
58. Sánchez-Ramos L, Briones DK, Kaunitz AM, DelValle GO, Gaudier FL & Walker CD (1994). Prevention of pregnancy-induced hypertension by calcium supplementation in angiotensin II sensitive patients. Obstetrics and Gynecology, 84: 349-353.
59. López-Jaramillo P, Guarner F & Moncada S (1987). Effects of calcium and parathyroid hormone on prostacyclin synthesis by vascular tissue. Life Sciences, 40: 983-986.
60. López-Jaramillo P, Narváez M & Yépez R (1987). Effect of calcium supplementation on the vascular sensitivity to angiotensin II in pregnant women. American Journal of Obstetrics and Gynecology, 156: 261-262.
61. Félix C, Jácome P, López A, Moya W, Narváez M & López-Jaramillo P (1991). The hypotensive effect of calcium supplementation during normal pregnancy in Andean women is not related to vascular production of prostacyclin by umbilical arteries. Journal of Obstetrics and Gynecology, 11: 93-96.
62. López-Jaramillo P, Terán E & Moncada S (1995). Calcium supplementation prevents pregnancy induced hypertension by increasing the production of vascular nitric oxide. Medical Hypotheses, 45: 68-72.
63. Palmer RMJ, Ashton DA & Moncada S (1988). Vascular endothelial cells synthetize nitric oxide from L-arginine. Nature, 333: 664-666.
64. Rees DD, Palmer RMJ & Moncada S (1989). Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proceedings of the National Academy of Sciences, USA, 86: 3374-3378.
65. Vallance P, Collier J & Moncada S (1989). Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet, ii: 997-1000.
66. Moncada S, Higgs EA, Hodson HF, Knowles RG, López-Jaramillo P, McCall T, Palmer RMJ, Radomski MW, Rees DD & Schultz R (1991). The L-arginine nitric oxide pathway. Journal of Cardiovascular Pharmacology, 17 (Suppl 3): S1-S9.
67. Palmer RMJ, Ferrige AG & Moncada S (1987). Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature, 327: 524-526.
68. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG & Moncada S (1994). Induction of calcium-dependent nitric oxide syntheses by sex hormones. Proceedings of the National Academy of Sciences, USA, 91: 5212-5216.
69. Weiner CP, Knowles RG & Moncada S (1994). Induction of nitric oxide synthases early in pregnancy. American Journal of Obstetrics and Gynecology, 171: 838-843
70. Conrad KP & Vernier KA (1989). Plasma level, urinary excretion and metabolic production of cGMP during gestation in rats. American Journal of Physiology, 257: R847-R853.
71. Conrad KP, Joffe GM, Kruszyna H, Kruszyna R, Rochelle LG, Smith RP, Chávez JE & Mosher MD (1993). Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB Journal, 7: 566-571.
72. Yallampalli C & Garfield RE (1993). Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. American Journal of Obstetrics and Gynecology, 169:1316-1320.
73. López-Jaramillo P, Sosa C & Leone A (1994). The L-arginine:nitric oxide pathway in normal pregnancy and preeclampsia. Canadian Journal of Physiology and Pharmacology, 72 (S1): 470 (Abstract).
74. López-Jaramillo P, Narvaez M, Félix C, Sosa C, Calle A, Nava E, Palmer RMJ & Moncada S (1992). Decreased nitric oxide synthesis in Andean Ecuadorian women with pregnancy induced hypertension. In: Moncada S, Marietta MA, Hibbs Jr JB & Higgs EA (Editors), Biology of Nitric Oxide. Portland Press, London, 376-379.
75. López-Jaramillo P, Narváez M, Calle A, Rivera J, Jácome P, Ruano C & Nava E (1996). Cyclic guanosine 3′,5′ monophosphate concentrations in preeclampsia: effects of hydralazine. British Journal of Obstetrics and Gynaecology, 103: 33-38.
76. Kawasaki N, Matsui K, Ito M, Nakamura T, Yoshimura T, Ushijima H & Maeyama M (1985). Effect of calcium supplementation on the vascular sensitivity to angiotensin II in pregnant women. American Journal of Obstetrics and Gynecology, 153: 576-582.
77. Tolins J, Palmer RM, Moncada S & Raij L (1990). Role of endothelium derived relaxing factor in regulation of renal hemodynamic responses. American Journal of Physiology, 258: H655-H662.
78. Luckhoff A, Pohl U, Mulsch A & Busse R (1988). Differential role of extra and intracellular calcium in the release of EDRF and prostacyclin from culture endothelial cells. British Journal of Pharmacology, 95: 189-196.
79. Palmer RMJ & Moncada S (1989). A novel citrulline forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. Biochemical and Biophysical Research Communications, 158: 348-352.
80. ++ concentration in the production of endothelial nitric oxide and the control of vascular tone. British Journal of Pharmacology, 101: 489-493.
81. ++ concentrations. European Journal of Pharmacology, 183: 643-644.
82. Bevan JA & Joyce EH (1993). Calcium dependence of flow induced dilation. Cooperative interaction with sodium. Hypertension, 21: 16-21.
83. Takasugi N (1993). Calcium induced vasodilation due to increase in nitric oxide formation in the vascular bed of rabbit ear preparation. Japanese Journal of Pharmacology, 61: 177-182.
84. Rubanyi GM, Romero JC & Vanhoutte PM (1986). Flow induced release of endothelium derived relaxing factor. American Journal of Physiology, 250: H1145-H1147.
85. Lansman JB, Hallam TJ & Rink TJ (1987). Single stretch activated ion channels in vascular endothelial cells as mechano transducers? Nature, 325: 811-813.
86. Demirel E, Laskey RE, Purkerson S & van Breemen C (1993). The passive calcium leak in cultured porcine aortic endothelial cells. Biochemical and Biophysical Research Communications, 191: 1197-1203.
87. Kopp L, Paradiz G & Tucci JR (1977). Urinary excretion of cyclic 3′5′ adenosine monophosphate and cyclic 3′5′ guanosine monophosphate during and after pregnancy. Journal of Clinical Endocrinology and Metabolism, 44: 590-594.
88. Broadus AE, Hardman JG & Kaminsky NI (1971). Extracellular cyclic nucleotides. Annals of the New York Academy of Sciences, 185: 50-66.
89. Gerzer R, Witzgall H, Tremblay J, Gutkowska J & Hamet P (1985). Rapid increase in plasma and cyclic GMP after bolus injection of atrial natriuretic factor in man. Journal of Clinical Endocrinology and Metabolism, 61: 1217-1219.
90. Lincoln TM & Cornwell TI (1991). Towards an understanding of the mechanism of action of cyclic AMP and cyclic GMP in smooth muscle relaxation. Blood Vessels, 28: 129-137.
91. - cotransport in vascular smooth cells. Journal of Biological Chemistry, 261: 1546-1548.
92. Steegers EA, Van Lakwijk H, Fast JH, Godschalx AW, Johgsma HW, Eskes TK, Symonds EM & Hein PR (1991). Atrial natriuretic peptide and atrial size during normal pregnancy. British Journal of Obstetrics and Gynaecology, 98: 202-207.
93. Malatino L, Stancanelli B & Greco G (1988). Atrial natriuretic peptide levels in normal pregnancy and the puerperium. Medical Sciences Research, 16: 1113-1116.
94. Thomsen JK, Storm TI, Thamsborg G, deNully M, Bodker B & Skouby S (1987). Atrial natriuretic peptide concentrations in preeclampsia. British Medical Journal, 294: 1508-1510.
95. Otsuki Y, Okamoto E, Iwata I, Nishino E, Mitsuda N, Mori M, Takagi T, Sugita N & Tanizawa O (1987). Changes in concentration of human atrial natriuretic peptide in normal pregnancy and toxaemia. Journal of Endocrinology, 114: 325-328.
96. Fievet P, Fournier A, De Bold A, el Esper N, Gregoire I, Westeel PF, Ranaud H & Makdassi R (1988). Atrial natriuretic factor in pregnancy-induced hypertension and pre-eclampsia; increased plasma concentrations possibly explaining these hypovolemic states with paradoxical hyporeninism. American Journal of Hypertension, 1: 16-21.
97. Walter U (1989). Physiological role of cGMP and cGMP-dependent protein kinase in the cardiovascular system. Reviews of Physiology, Biochemistry and Pharmacology, 113: 41-87.
98. Pickling SA, Williams D, Vallance P, Nussey SS & Whitley GS (1993). Plasma concentration of an endogenous inhibitor of nitric oxide synthesis in normal pregnancy and preeclampsia. Lancet 342: 242-243.
99. López-Jaramillo P (1993). Papel del consumo de calcio dietético en la génesis y prevención de la preeclampsia en embarazadas andinas ecuatorianas. Endocrinología Ecuatoriana, 2: 64-74.